Search

everythinglearnresearchcommunity

for

Search:↓

Low Vitamin D, Vitamin B12, and iron levels, as well as thyroid issues, are strongly linked to premature greying of hair, which also negatively affects quality of life.

Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Low zinc levels in chronic liver disease patients are linked to more severe symptoms like taste issues and skin problems, and zinc supplements might help.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Early-onset hair loss in young males is linked to a higher risk of metabolic syndrome.

The most common causes of hair loss in a Nigerian hospital were discoid lupus erythematosus of the scalp and alopecia areata, and more research is needed to understand and address these issues.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

The document's conclusion cannot be summarized because the content is not accessible or understandable.

Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.

Hair changes can indicate systemic diseases or medication effects.

Skin has a larger surface area than thought, certain skin cells improve skin flap survival, better trials for skin conditions in children are needed, Stevens-Johnson syndrome rates vary by age and race, and better skin barrier function may reduce inflammation in the elderly.

Skin infections and eczema were most common in all ages, acne in teens and young adults, and nutritional skin problems and infestations in children.

Targeting the skin's endocannabinoid system could help treat skin disorders.

A 3-year-old girl developed scurvy symptoms that improved with vitamin C but relapsed when supplementation stopped.

Dermatoscopy and videodermatoscopy are useful for diagnosing and monitoring various skin, hair, and nail conditions.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

UV radiation can help sterilize wounds and promote healing but requires careful use to avoid damaging cells.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

A 5% minoxidil spray could effectively treat male baldness with fewer side effects and better patient comfort.